Add to Cart View Cart/Checkout More Products

Volume 11, 2007 CD

Six back issues of The International Journal of Pharmaceutical Compounding from 2007 on one convenient CD.
Only $95 per CD.
(Multiple Theme or Library CD orders priced at: 2 to 5 = $85; 6 to 9 = $75; 10 or more = $65 each.)

  • Permanant storage and easy retrieval of IJPC articles, formulations, SOP's and more.
  • Print IJPC articles in color for your marketing needs.

The back issues are stored as a high-resolution, full-color Adobe Portable Document Format (.pdf) file, complete with an electronic Table of Contents.

They may be searched by keyword and printed by the page. Software to read the PDF file is freely available from the Adobe Reader page.

Issues
Volume/IssueDateTitle
Vol. 11 No. 1 January/February 2007 Pediatric Patients
Vol. 11 No. 2 March/April 2007 Diabetes
Vol. 11 No. 3 May/June 2007 Pain Management
Vol. 11 No. 4 July/August 2007 Hormone Replacement Therapy
Vol. 11 No. 5 September/October 2007 Veterinary Compounding
Vol. 11 No. 6 November/December 2007 High-Technology Compounding

Articles
Volume/IssuePageTitle
Vol. 11 No. 1 2 PreScription: IJPC: The Next 10 Years
Vol. 11 No. 1 5 Need for Appropriate Formulations for Children: The National Institute of Child Health and Human Development—Pediatric Formulations Initiative, Part 1
Vol. 11 No. 1 10 Principles of Pediatric Palliative Care and Pain Control
Vol. 11 No. 1 17 Pediatric Oral Formulations: A Continual Challenge
Vol. 11 No. 1 20 Sevelamer Suspension in Children with End-Stage Renal Disease
Vol. 11 No. 1 26 Case Report: Cocktail Dosing in a Premature Infant with a History of Cholestasis
Vol. 11 No. 1 27 Case Report: Treatment of Labial Adhesions in a Child
Vol. 11 No. 1 28 Compounding In Crisis:The Aftermath of Hurricane Katrina
Vol. 11 No. 1 36 Information Resources and Software for the Hospital Compounding Pharmacist
Vol. 11 No. 1 44 Psychotropic Medications in the Treatment of Feline Urine Spraying
Vol. 11 No. 1 50 Basics of Compounding for Hazardous Drugs, Part 3: Safe Handling and Personal Protection
Vol. 11 No. 1 52 Quality Control Analytical Methods: The Quality of Sterility Testing
Vol. 11 No. 1 56 Collaborative Drug Therapy Management and its Application to Pharmaceutical Compounding
Vol. 11 No. 1 59 Pharmacogenomics: The End of Trial-and-Error Medicine?
Vol. 11 No. 1 66 Standard Operating Procedure: Refrigerator—Installation,Maintenance, Cleaning, and Power Interruptions
Vol. 11 No. 1 68 Calculations
Vol. 11 No. 1 69 Caffeine Citrate 10-mg/mL Oral Liquid
Vol. 11 No. 1 70 Carbidopa 1.25-mg/mL Oral Liquid
Vol. 11 No. 1 71 Clonidine Hydrochloride 0.1-mg/mL Oral Liquid
Vol. 11 No. 1 72 Dexamethasone 1-mg/mL Oral Liquid
Vol. 11 No. 1 73 Fluoxetine Hydrochloride 1-mg/mL Oral Liquid
Vol. 11 No. 1 74 Lansoprazole 3-mg/mL Oral Liquid
Vol. 11 No. 1 75 Methyldopa 25-mg/mL Oral Liquid
Vol. 11 No. 1 76 Metolazone 1-mg/mL Oral Liquid
Vol. 11 No. 1 77 Prednisone 10-mg/mL Oral Liquid
Vol. 11 No. 1 78 Prednisolone Sodium Phosphate 10-mg/mL Oral Liquid
Vol. 11 No. 1 79 Chemical Stability of Desonide in Ear Drops
Vol. 11 No. 1 82 Physical and Chemical Stability of Palonosetron with Metoclopramide and Promethazine During Simulated Y-Site Administration
Vol. 11 No. 1 88 PostScription: IJPC—More Than a Journal
Vol. 11 No. 2 92 PreScription: Putting the Science Back into Pharmacy
Vol. 11 No. 2 95 Insulins: Historical and Current Perspectives
Vol. 11 No. 2 106 Compounding for the Complications of Diabetes: Interviews with Compounding Pharmacists George B. Muller, RPh, and Jerrod Roberts, DPh
Vol. 11 No. 2 112 Certified Diabetes Educator: A Credential for Compounding Pharmacists
Vol. 11 No. 2 116 Challenges of Compounding for Patients on the Ketogenic Diet
Vol. 11 No. 2 122 Compounded Treatments for Erectile Dysfunction: A Common Complication of Diabetes
Vol. 11 No. 2 126 Including Pets in Diabetic Care
Vol. 11 No. 2 131 Case Report: Shingles Triple Cream in the Treatment of Herpes Zoster
Vol. 11 No. 2 132 Innovative Uses of Compounded Tranilast: An Interview with Compounding Pharmacist Larry J. Frieders, RPh
Vol. 11 No. 2 138 Records and Record-Keeping for the Hospital Compounding Pharmacist
Vol. 11 No. 2 145 Quality Control Analytical Methods: Considerations in Compounding Peroral Solid Dosage Forms
Vol. 11 No. 2 149 Basics of Compounding for Hazardous Drugs, Part 4: Developing the Hazardous Drugs List and Containment Workstations
Vol. 11 No. 2 152 Calculations
Vol. 11 No. 2 153 Standard Operating Procedure: Discarding of Broken Glass
Vol. 11 No. 2 154 Aspirin 80-mg/5-mL Oral Liquid, Anhydrous
Vol. 11 No. 2 155 Busulfan 2-mg/mL Oral Liquid
Vol. 11 No. 2 156 Cefuroxime Axetil 10-mg/mL Oral Liquid
Vol. 11 No. 2 157 Metformin Hydrochloride 100-mg/mL Oral Liquid
Vol. 11 No. 2 158 Ondansetron Hydrochloride 0.8mg/mL Oral Liquid
Vol. 11 No. 2 159 Oral Liquid Vehicle, Anhydrous
Vol. 11 No. 2 160 Phenoxybenzamine Hydrochloride 2-mg/mL Oral Liquid
Vol. 11 No. 2 161 Ranitidine Hydrochloride 15-mg/mL Oral Liquid
Vol. 11 No. 2 162 Tegaserod Meleate 0.1-mg/mL Oral Liquid
Vol. 11 No. 2 163 Triprolidine Hydrochloride 0.25-mg/mL Syrup
Vol. 11 No. 2 164 Stability of Oseltamivir in Various Extemporaneous Liquid Preparations
Vol. 11 No. 2 178 PostScription: Responsibility: A Critical Aspect of Compounding Pharmacy
Vol. 11 No. 3 178 PreScription: State or Federal Control of Pharmacy Practice
Vol. 11 No. 3 181 Transdermal Gel in the Treatment of Postoperative Pain
Vol. 11 No. 3 187 Oral Methadone for Management of Regional Sympathetic Dystrophy Syndrome: A Case Revisited
Vol. 11 No. 3 194 The Rectal Rocket: A Two-Day Treatment for Hemorrhoids
Vol. 11 No. 3 200 Case Report: Ketoprofen/Riboflavin/Caffeine Capsules and Progesterone Therapy for Recurrent Migraine Pain
Vol. 11 No. 3 202 Levorphanol for the Treatment of Severe Chronic Pain
Vol. 11 No. 3 212 Levorphanol for Excruciating Pain from Oral Cancer: A Case Report
Vol. 11 No. 3 220 Need for Appropriate Formulations for Children: The National Institute of Child Health and Human Development--Pediatric Formulations Initiative, Part 2
Vol. 11 No. 3 226 Quality Control: Standard Operating Procedures--An Essential Tool for Developing Quality Preparations
Vol. 11 No. 3 230 Basics of Compounding for the Implementation of United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 1
Vol. 11 No. 3 238 Calculations - Compounding for Pain Management
Vol. 11 No. 3 240 Standard Operating Procedure: Basic Compounding Documentation--the Master Formula Form
Vol. 11 No. 3 242 Benazepril 2-mg/mL Oral Liquid
Vol. 11 No. 3 243 Cholecalciferol 40,000-IU/mL Oral Liquid
Vol. 11 No. 3 244 Folic Acid 1-mg/mL Oral Liquid
Vol. 11 No. 3 245 Glycopyrrolate 0.5-mg/mL Oral Liquid
Vol. 11 No. 3 246 Isoproterenol Compound Elixir
Vol. 11 No. 3 247 Levothyroxine Sodium 40-micro-g/mL Oral Liquid
Vol. 11 No. 3 248 Losartan Potassium 2.5-mg/mL Oral Liquid
Vol. 11 No. 3 249 Methylphenidate 1-mg/mL Oral Liquid
Vol. 11 No. 3 250 Thiamine Hydrochloride 100-mg/mL Oral Liquid
Vol. 11 No. 3 251 Trovafloxacin Mesylate 10-mg/mL Oral Liquid
Vol. 11 No. 3 252 Rheologic Profile, Specific Gravity, Surface Tension, and pH of Fifteen Over-the-Counter Preparations
Vol. 11 No. 3 259 Chemical Stability of Hydrocortisone in an Oral Liquid Dosage Form without Suspending Agents
Vol. 11 No. 3 262 PostScription: Lobbying: How It Affects Compounding
Vol. 11 No. 4 266 PreScription: Bias, NAMS, and HRT
Vol. 11 No. 4 269 Correcting Misconceptions about Compounding Bioidentical Hormones: A Review of the Literature
Vol. 11 No. 4 274 The History of Progesterone
Vol. 11 No. 4 278 The Politics of Hormone Replacement Therapy
Vol. 11 No. 4 282 Premarin: The Intriguing History of a Controversial Drug
Vol. 11 No. 4 288 Common Acronyms Used by Health Professionals Who Prescribe or Prepare Hormone Replacement
Vol. 11 No. 4 292 The Lived Experience of Perimenopausal and Menopausal Women Undergoing Treatment with Bioidentical Hormones
Vol. 11 No. 4 297 Obtaining Accreditation by the Pharmacy Compounding Accreditation Board, Part 1: An Overview
Vol. 11 No. 4 300 Book Review: The Rexall Story: A History of Genius and Neglect
Vol. 11 No. 4 302 Update on the Proposed Revision Process for United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations
Vol. 11 No. 4 306 Quality-control Analytical Methods: Logbooks and Documentation Forms
Vol. 11 No. 4 314 Basics of Compounding: The Responsibilities of Compounding Personnel in Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 2
Vol. 11 No. 4 324 Calculations
Vol. 11 No. 4 326 Standard Operating Procedure: U.S. Food and Drug Administration Inspection--Releasing a Sample to the U.S. Food and Drug Administration
Vol. 11 No. 4 328 Fentanyl 50-mg/mL in 0.9% Sodium Chloride Solution
Vol. 11 No. 4 329 Ketoconazole 25-mg Liquid Suppository
Vol. 11 No. 4 330 Mebeverine Hydrochloride 20% gel
Vol. 11 No. 4 331 Moxifloxacin in Dianeal 1.36% Peritoneal Dialysis Solution
Vol. 11 No. 4 332 Oseltamivir 12-mg/mL Oral Suspension
Vol. 11 No. 4 333 Phenytoin Sodium 20-mg/mL Topical Suspension
Vol. 11 No. 4 334 Ribavirin 40-mg/mL Suspension
Vol. 11 No. 4 335 Sufentanil 50-mg/mL in 0.9% Sodium Chloride Solution
Vol. 11 No. 4 336 Temozolomide 10-mg/mL Oral Liquid
Vol. 11 No. 4 337 Vehicle N Formulas
Vol. 11 No. 4 338 Statistical Analysis of Barrier Isolator/Glovebox Glove Failure
Vol. 11 No. 4 347 Chemical Stability of Cyproheptadine Hydrochloride in an Oral Liquid Dosage Form
Vol. 11 No. 4 350 PostScription: Thousands of Unapproved New Drugs are on the U.S. Market, Part 1
Vol. 11 No. 5 354 PreScription: Pharmacy Education: Is It Contemporary?
Vol. 11 No. 5 357 United States Pharmacopeia Convention Standards and Clinical Information for Compounded Medications Used in Veterinary Medicine
Vol. 11 No. 5 364 Rabbit Medicine
Vol. 11 No. 5 376 The Whales: A Pharmacist's Story
Vol. 11 No. 5 384 Equine Cushing's Disease: A Clinical Update
Vol. 11 No. 5 390 Submitting Compelling Case Reports for Drug Therapy in Veterinary Patients
Vol. 11 No. 5 397 Obtaining Accreditation by the Pharmacy Compounding Accreditation Board, Part 2: Developing Essential Standard Operating Procedures
Vol. 11 No. 5 400 Quality-Control Analytical Methods: A Discussion of United States Pharmacopeia Chapter <71> Sterility Tests
Vol. 11 No. 5 404 Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 3: Risk Levels
Vol. 11 No. 5 412 Calculations: Compounding for Veterinary Patients
Vol. 11 No. 5 414 Standard Operating Procedure: Complaint and Mishap Rectification
Vol. 11 No. 5 416 Acetaminophen 500-mg and Diphenhydramine Hydrochloride 25-mg Hot Therapy Packs
Vol. 11 No. 5 417 Acetylcysteine 200-mg/mL Oral Liquid
Vol. 11 No. 5 418 Acetylcysteine 200-mg Packets
Vol. 11 No. 5 419 Betamethasone Valerate 0.1% Topical Gel
Vol. 11 No. 5 420 Dexpanthenol 5% Gel-Cream
Vol. 11 No. 5 421 Diclofenac Sodium 75-mg/mL Injection
Vol. 11 No. 5 422 Ergonovine Maleate 0.2-mg/mL Injection, Veterinary
Vol. 11 No. 5 423 Hydrocortisone 0.5% Ethanolic Gel
Vol. 11 No. 5 424 Neomycin 0.05% Topical Gel
Vol. 11 No. 5 425 Nondetergent Neutral Dry Skin Cream
Vol. 11 No. 5 426 Zinc Content of Commercial Diluents Widely Use in Drug Admixtures Prepared for Intravenous Infusion
Vol. 11 No. 5 433 Isoniazid Release from Suppositories Compounded with Selected Bases
Vol. 11 No. 5 438 PostScription: Thousands of Unapproved New Drugs are on the U.S. Market, Part 2
Vol. 11 No. 6 442 PreScription: Thoughts on Technology and Pharmacy
Vol. 11 No. 6 445 The Internet on Steroids: How Connected is Your Pharmacy?
Vol. 11 No. 6 450 Achievement of USP Chapter <797> Compliance by a 35-Bed Rural Hospital: A Case Study
Vol. 11 No. 6 472 The Internet and Its Websites: Your New Business Partner
Vol. 11 No. 6 476 Proteins Used as Sweeteners
Vol. 11 No. 6 483 Soda Jerk
Vol. 11 No. 6 487 Quality-Control Analytical Methods: In-House Quality Control of Simple Compounds
Vol. 11 No. 6 492 Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 4: Considerations in Selection and Use of Disinfectants and Antiseptics
Vol. 11 No. 6 500 Calculations: High-Technology Compounding and Investigational Dispensing
Vol. 11 No. 6 502 Standard Operating Procedure: Vial Crimper--Use, Care, Cleaning, and Maintenance
Vol. 11 No. 6 504 Aloe Vera Gel
Vol. 11 No. 6 505 Breast Care Cream
Vol. 11 No. 6 506 Castor Oil and Trypsin Ointment
Vol. 11 No. 6 507 Chlorhexidine 2% Gel
Vol. 11 No. 6 508 Coal Tar 2% and Allantoin 2.5% Cream
Vol. 11 No. 6 509 Foscarnet 2.5% Topical Cream
Vol. 11 No. 6 510 Interferon alfa-2b Ophthalmic Solution
Vol. 11 No. 6 511 Lidocaine Hydrochloride 1.82% Buffered Injection
Vol. 11 No. 6 512 Miconazole 2% Oral Gel
Vol. 11 No. 6 513 Sodium Phenylbutyrate 200-mg/mL Oral Liquid
Vol. 11 No. 6 514 Topical Pain Relief: Assessment of Patient Satisfaction with a Novel Compound Containing at Least Ketoprofen
Vol. 11 No. 6 520 Palonosetron Hydrochloride Compatibility and Stability with Three Beta-Lactam Antibiotics During Simulated Y-Site Administration
Vol. 11 No. 6 526 PostScription: The History of Pharmacy